Journal of Inflammation Research

Dove Medical Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Inflammation Research is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Dove Medical Press
ISSN
1178-7031
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
4,320 USD
Articles in DOAJ
4044
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2009-04-16
  • PUBMED · 2009-01-01
Indexing
DOAJ · PUBMED
APC
4,320 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

4044

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

4224

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

81

i10-index

1456

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-04-27
Added to DOAJ
2009-04-16
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
84%
ORCID iDs in current deposits
71%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101512684
Classification4

Subjects (DOAJ)

Medicine: PathologyMedicine: Therapeutics. Pharmacology

LCC codes

RB1-214RM1-950

Subject areas

  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Inflammasome and immune disorders
  • Inflammasome and immune disorders
  • Sepsis Diagnosis and Treatment
  • Sepsis Diagnosis and Treatment
Show all subjects (50)
  • Immune Response and Inflammation
  • Immune cells in cancer
  • Immune Response and Inflammation
  • Immune cells in cancer
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Inflammatory Bowel Disease
  • Inflammatory Bowel Disease
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Inflammation biomarkers and pathways
  • Gut microbiota and health
  • Gut microbiota and health
  • Inflammation biomarkers and pathways
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • COVID-19 Clinical Research Studies
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • COVID-19 Clinical Research Studies
  • Cancer-related molecular mechanisms research
  • Cancer Immunotherapy and Biomarkers
  • Cancer-related molecular mechanisms research
  • Cancer Immunotherapy and Biomarkers
  • Asthma and respiratory diseases
  • Psoriasis: Treatment and Pathogenesis
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Psoriasis: Treatment and Pathogenesis
  • Atherosclerosis and Cardiovascular Diseases
  • Asthma and respiratory diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiac Fibrosis and Remodeling
  • Osteoarthritis Treatment and Mechanisms
  • Osteoarthritis Treatment and Mechanisms
  • Cardiac Fibrosis and Remodeling
  • Dermatology and Skin Diseases
  • Dermatology and Skin Diseases
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Biomarkers in Disease Mechanisms
  • Tryptophan and brain disorders
  • Biomarkers in Disease Mechanisms
  • Tryptophan and brain disorders

Keywords (DOAJ)

  • inflammation
  • anti-inflammatory drugs

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: